0000788611 false 0000788611 2022-02-16 2022-02-16 0000788611 SGLB:CommonStockParValue0.001PerShareMember 2022-02-16 2022-02-16 0000788611 SGLB:WarrantsToPurchaseCommonStockParValue0.001PerShareMember 2022-02-16 2022-02-16 iso4217:USD xbrli:shares iso4217:USD xbrli:shares

 

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

 

FORM 8-K

 

CURRENT REPORT

PURSUANT TO SECTION 13 OR 15(D) OF THE

THE SECURITIES EXCHANGE ACT OF 1934

 

Date of report (Date of earliest event reported): February 16, 2022

 

SIGMA LABS, INC.

(Exact name of registrant as specified in its charter)

 

Nevada   001-38015   27-1865814

(State or other jurisdiction of

incorporation or organization)

 

(Commission

File Number)

 

(I.R.S. Employer

Identification No.)

 

3900 Paseo del Sol

Santa Fe, New Mexico 87507

(Address of Principal Executive Offices) (Zip Code)

 

Registrant’s telephone number, including area code: (505) 438-2576

 

 

Former name or former address, if changed since last report

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):

 

Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
   
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
   
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
   
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

 

Securities registered pursuant to Section 12(b) of the Act:

 

Title of each class   Trading Symbol(s)   Name of each exchange on which registered
Common Stock, par value $0.001 per share   SGLB   The NASDAQ Stock Market LLC
Warrants to Purchase Common Stock, par value $0.001 per share   SGLBW   The NASDAQ Stock Market LLC

 

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§ 230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§ 240.12b-2 of this chapter).

 

Emerging growth company

 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

 

 

 

 
 

 

Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.

 

On February 16, 2022, the Board of Directors (the “Board”) of Sigma Labs, Inc. (“we,” “our,” “us” or the “Company”) promoted Jacob Brunsberg to serve as President and Chief Operating Officer of the Company. Prior to the promotion, Mr. Brunsberg served since September 20, 2021 as Senior Vice President Product Marketing and Strategic Relationships of the Company pursuant to an at-will employment letter agreement effective as of September 20, 2021. Mr. Brunsberg’s employment letter agreement with the Company remains in place in accordance with its terms except for the change in Mr. Brunsberg’s titles and duties and an increase in his annual base salary from $200,000 to $250,000.

 

Under the employment letter agreement, as amended Mr. Brunsberg (i) is entitled to an annual base salary of $250,000, which may be increased (but not decreased) in the discretion of the Compensation Committee of the Board based on annual or special case assessments of Mr. Brunsberg’s performance and other factors, (ii) is entitled to all benefits that we elect in our sole discretion to provide from time to time to our other executive officers, and (iii) was previously granted under the Company’s 2013 Equity Incentive Plan (the “2013 Plan”) a five-year stock option to purchase up to 100,000 shares of common stock of the Company at an exercise price of $3.18 (i.e., the closing price of the Company’s common stock on the grant date), and is fully vested. The option is on such other terms and provisions as are contained in the Company’s standard-form nonqualified stock option agreement. Additionally, during the term of his employment, Mr. Brunsberg will be eligible to receive additional equity grants under the Company’s incentive plans and additional grants of stock appreciation rights. Mr. Brunsberg will also be eligible to receive one or more bonuses relating to each fiscal year in recognition of his achievement of individual and Company goals established by the Board from time to time. However, the decision to provide any such bonuses and the amount and terms of any such bonuses will be in the sole discretion of the Board. For 2021, Mr. Brunsberg received a cash bonus of $19,876.

 

Mr. Brunsberg will perform such duties as are customarily performed by individuals acting as President and Chief Operating Officer of a public company of a similar size as the Company and such other such duties as may be assigned to him from time to time by the Chief Executive Officer or the Board.

 

In connection with Mr. Brunsberg’s promotion, on February 16, 2022 (the “Grant Date”), the Company granted Mr. Brunsberg pursuant to the 2013 Plan a five-year stock option to purchase up to 70,000 shares of common stock of the Company at an exercise price of $2.50. The option will vest and become exercisable in equal (as closely as possible) monthly installments over three years from the Grant Date, provided, in each case, that Mr. Brunsberg remains an employee of the Company through the applicable vesting date, and is on such other terms and provisions as are contained in the Company’s standard-form nonqualified stock option agreement The Company also granted to Mr. Brunsberg pursuant to the Company’s 2020 Stock Appreciation Rights Plan (the “2020 Plan”) 30,000 stock appreciation rights (“SARs”) with an exercise price per SAR of $2.50. The SARs will expire on the fifth anniversary of the Grant Date unless previously settled, may be settled only in cash, will vest in equal (as closely as possible) monthly installments over three years from the Grant Date, provided, in each case, that Mr. Brunsberg remains an employee of the Company through the applicable vesting date, and, in the event of a Change in Control (as defined in the 2020 Plan) will become immediately vested and exercisable as long as Mr. Brunsberg is in the Company’s employ immediately prior to the Change in Control, and will otherwise be on such other terms set forth in the Company’s standard-form of stock appreciation rights agreement.

 

Prior to joining the Company in September 2021, Mr. Brunsberg, 35, served from 2019 to September 2021 as Product Line Leader and Acting General Manager – Binder Jet Technology (Munich, Germany), of General Electric, in which role he was responsible for product portfolio, roadmap, R&D, development, commercialization and operational performance, and served from 2017 to 2019 as Senior Managing Director – Central Region (North America) of General Electric, in which role he was part of the leadership team that was tasked with establishing U.S. sales infrastructure for post-acquisition integration of several additive manufacturing technology companies, including Concept Laser, Arcam and GEonX into the newly formed GE Additive business entity. Prior to joining General Electric in 2017, he held various senior positions from 2009 to 2017 in American Roller Company, a manufacturer of industrial rollers. Mr. Brunsberg received his Bachelor of Science degree in Materials Science and Engineering from the University of Wisconsin-Madison.

 

 
 

 

There are no arrangements or understandings between Mr. Brunsberg and any other persons pursuant to which he was appointed as President and Chief Operating Officer of the Company. There are no family relationships between Mr. Brunsberg and any of the Company’s directors, executive officers or persons nominated or chosen by the Company to become a director or executive officer. Mr. Brunsberg is not a party to any current or proposed transaction with the Company for which disclosure is required under Item 404(a) of Regulation S-K.

 

The foregoing description of Mr. Brunsberg’s employment letter agreement, as amended, does not purport to be a complete description of the terms and conditions therein. The full text of such agreement will be filed as an exhibit to our Annual Report on Form 10-K for the fiscal year ended December 31, 2021.

 

In connection with Mr. Brunsberg’s promotion as the Company’s President and Chief Operating Officer, Mark Ruport, the Company’s Chief Executive Officer, resigned as President of the Company, effective February 16, 2022. Mr. Ruport will remain the Chief Executive Officer of the Company at an annual base salary of $200,000 (a decrease from $250,000) and continue to serve as a Board member.

 

On February 17, 2022, the Company issued a press release announcing Mr. Brunsberg’s promotion, a copy of which is attached to this Report as Exhibit 99.1 and is incorporated herein by reference. The information furnished under Exhibit 99.1 shall not be deemed to be “filed” for the purposes of Section 18 of the Securities Exchange Act of 1934 (the “Exchange Act”), or otherwise subject to the liability of such section, nor shall such information be deemed to be incorporated by reference in any previous or subsequent filing by the company under the Securities Act of 1933 or the Exchange Act, regardless of the general incorporation language of such filing, except as specifically stated in such filing.

 

Item 9.01 Financial Statements and Exhibits.

 

(d) Exhibits

 

Exhibit Number   Description
99.1   Press Release of Sigma Labs, Inc., dated February 17, 2022
104   Cover Page Interactive Data File (embedded within the Inline XBRL document)

 

 
 

 

SIGNATURES

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

Date: February 17, 2022 SIGMA LABS, INC.
     
  By: /s/ Mark K. Ruport
  Name:  Mark K. Ruport
  Title: Chief Executive Officer

 

 

 

 

Exhibit 99.1

 

 

Sigma Labs Promotes Jacob Brunsberg to President and Chief Operating Officer

 

AM Industry Leader to Advance Sigma’s Newly Launched Strategic Initiatives, Scale Company with Software Only Solution, and Accelerate and Expand OEM and Partner Ecosystem

 

SANTA FE, NM – February 17, 2022 – Sigma Labs, Inc. (NASDAQ: SGLB) (“Sigma Labs”), a leading developer of quality monitoring, analytics and assurance software to the commercial 3D printing industry, has named Jacob Brunsberg to the position of President and Chief Operating Officer. Brunsberg will have responsibility for product direction, strategic relationships, sales, marketing, and engineering. As president, he will report to Mark K. Ruport, Sigma’s CEO.

 

Brunsberg will oversee several strategic initiatives designed to accelerate the growth and performance of the company, including the transition to a software only offering, initiating and implementing a comprehensive OEM integration program, building strategic partnerships, and implementing a new subscription-based pricing model. Each of these key initiatives is integral to lowering the additive manufacturing (“AM”) industry’s technology adoption barriers and easing entry and expansion for manufacturers and OEM partners.

 

Jacob Brunsberg stated, “I am humbled and excited to accept the new role and responsibility. I came to Sigma Labs with a passion for industrializing additive manufacturing and am honored to be able to lead and serve a team with this level of talent, potential, and technology. Our mission is to accelerate the adoption of additive manufacturing by setting the standard for in-situ quality monitoring and analytics. With customer success at the forefront, we will practice radical collaboration with the goal of driving costs out of the additive process chain, ensuring reliability and repeatability, and delivering a standardized approach to quality across the entire additive manufacturing landscape.”

 

Prior to joining Sigma Labs in September 2021 as Senior Vice President responsible for leading the company’s strategic relationships, product management and marketing programs, Brunsberg was a P&L leader for General Electric’s Binder Jet Technology unit with management responsibility for strategy, development, commercialization, and overall business performance. He has a degree in material science from the University of Wisconsin.

 

According to Mark Ruport, CEO of Sigma Labs, “Jacob has earned the respect of Sigma’s employees, management, board of directors, customers, and partners. His passion for the industry, ability to chart the company’s product direction, communicate our strategy to potential partners, and execute, has increased our confidence in both our strategic direction as well as our decision to elevate Jacob’s role. His promotion to president and COO reflects our confidence in Jacob and gives him full authority in the areas that will move our company forward.”

 

 
 

 

About Sigma Labs

 

Sigma Labs Inc. is a leading provider of in-process quality assurance (IPQA™) software to the additive manufacturing industry. Sigma Labs specializes in the development and commercialization of real-time monitoring and analytics solutions known as PrintRite3D® for 3D metal and polymer advanced manufacturing technologies. PrintRite3D detects and classifies defects and anomalies real-time during the manufacturing process, enabling significant cost-savings and production efficiencies. Sigma Labs believes its software product will be a major catalyst for the acceleration and adoption of industrial 3D printing. For more information, please visit www.sigmalabsinc.com.

 

Forward-Looking Statements

 

This press release contains “forward-looking statements” within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended (which Sections were adopted as part of the Private Securities Litigation Reform Act of 1995). Statements preceded by, followed by or that otherwise include the words “believe,” “anticipate,” “estimate,” “expect,” “intend,” “plan,” “project,” “prospects,” “outlook,” and similar words or expressions, or future or conditional verbs such as “will,” “should,” “would,” “may,” and “could” are generally forward-looking in nature and not historical facts. These forward-looking statements involve known and unknown risks, uncertainties and other factors. Among the important factors that could cause actual results to differ materially from those indicated by such forward-looking statements are risks relating to, among other things, market and other conditions, Sigma Labs’ business and financial condition, the extent of the market’s acceptance of PrintRite3D® version 7.0, Sigma Labs’ ability to satisfy its capital needs through increasing its revenue and obtaining additional financing, and the impact of COVID-19, general economic, industry or political conditions in the United States or internationally. The Company disclaims any intention to, and undertakes no obligation to, revise any forward-looking statements, whether as a result of new information, a future event, or otherwise. For additional risks and uncertainties that could impact the Company’s forward-looking statements, please see disclosures contained in Sigma Labs’ public filings with the SEC, including the “Risk Factors” in Sigma Labs’ Annual Report on Form 10-K, and which may be viewed at www.sec.gov.

 

CONTACT:
Investor Contact:

 

Chris Tyson
Executive Vice President
MZ Group - MZ North America
949-491-8235
SGLB@mzgroup.us
www.mzgroup.us

 

Company Contact:
Steven Gersten
Sigma Internal IR
813-334-9745
investors@sigmalabsinc.com